Brief: Strides Pharma Science Enters Agreement To Buy, In-License Generic Brands From Sandoz In Africa
17/03/2026 12:35
March 17 (Reuters) - Strides Pharma Science Ltd SRID.NS: STRIDES PHARMA SCIENCE LTD - ENTERS AGREEMENT TO BUY AND IN-LICENSE GENERIC BRANDS FROM SANDOZ IN AFRICA STRIDES PHARMA SCIENCE LTD - INITIAL CONSIDERATION FOR TRANSACTION IS US$ 12 MILLION STRIDES PHARMA SCIENCE LTD - DEAL EXPECTED TO CLOSE BY END OF Q2 FY27 PENDING REGULATORY APPROVALS Source text: ID:nBSE8gPcSB Further company coverage: SRID.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees